Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) EBT Margin (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of EBT Margin data on record, last reported at 218.49% in Q4 2025.

  • For Q4 2025, EBT Margin rose 20574.0% year-over-year to 218.49%; the TTM value through Dec 2025 reached 75.71%, up 7402.0%, while the annual FY2025 figure was 19.29%, 1761.0% up from the prior year.
  • EBT Margin reached 218.49% in Q4 2025 per INDV's latest filing, up from 11.78% in the prior quarter.
  • Across five years, EBT Margin topped out at 218.49% in Q4 2025 and bottomed at 40.47% in Q2 2024.